Biotech Co.* | Biotech Co.* | Product | Terms/Details (Date) |
| | |||
BioInvent International | CellControl Biomedical Laboratories AG* (Germany) | ACA-125 antibody | Agreement is for BioInvent to com- plete large-scale cGMP manufacturing of CellControl's ACA-125 antibody for Phase III trials, as well as to provide regulatory support (4/12) |
BioReliance Corp. (BREL) | Celltech Group plc (UK; NYSE:CLL; LSE:CCH) | Clinical-grade antibody fragment-based drugs | BioReliance will manufacture and supply the drugs to Celltech; the contract provides for BioReliance to support three product candidates in 2002, plus a minimum of two additional candidates in earlier stages of development during 2003 (3/26) |
Cepheid Inc. (CPHD) | Bucher Biotec AG* (Switzerland) | Smart Cycler system, accessories and disposable reaction tubes | Bucher will provide marketing, sales and service support for the Smart Cycler line in Switzerland (5/22) |
Immunex Corp. (IMNX) | Genentech Inc. (NYSE:DNA) | Enbrel | Manufacturing agreement in which Genentech will produce Enbrel at its facility in South San Francisco (4/15) |
Lipid Sciences Inc. (LIPD) | Progen Industries Ltd. (Australia; PGLAF) | Human plasma samples taken from healthy volunteers with elevated plasma cholesterol | The manufacturing contract is worth more than $267,000; Progen is responsible for manufacturing and clinical support for Lipid's Phase I trial (4/11) |
Zycos Inc.* | Pharmexa A/S (Denmark) | A therapeutic DNA breast cancer vaccine in Zyco's Gencap system | Zycos will formulate Pharmexa's therapeutic DNA breast cancer vaccine in Zycos' Gencap system; Pharmexa intends to use the Gencap technology to deliver its AutoVac HER-2 DNA vaccine for a Phase II study; Pharmexa will pay Zycos for formulation, manufacturing and scale-up; it also will make potential milestone and royalty payments (5/15) |
| | |||
Notes: | |||
# The information in the chart does not cover agricultural agreements. | |||
* Private companies are indicated with an asterisk. | |||
Unless otherwise noted, stock symbols listed are on the Nasdaq market. | |||
ND = Not disclosed, reported and/or available. | |||
LSE = London Stock Exchange; NYSE = New York Stock Exchange; SSE = Stockholm Stock Exchange | |||
